Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA
NCT01139658 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1676
Last updated 2014-01-16
Summary
Observational cohort study on the prevention of venous thromboembolic events after elective orthopaedic surgery for Total Knee Replacement or Total Hip Replacement iin patients treated with PRADAXA to evaluate the efficacy ant safety of Pradaxa in real-life conditions
Conditions
- Venous Thromboembolism
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- France
Study Locations
More Related Trials
-
Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
NCT03299296 ·Status: UNKNOWN ·Phase: PHASE3
-
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery
NCT00168818 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
NCT01184989 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
NCT00555438 ·Status: COMPLETED ·Phase: PHASE4
-
ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
NCT06611319 ·Status: RECRUITING ·Phase: PHASE3
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00452530 ·Status: COMPLETED ·Phase: PHASE3
-
Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Using Propensity Score Matching
NCT03483181 ·Status: UNKNOWN
-
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00371683 ·Status: COMPLETED ·Phase: PHASE3
-
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
NCT06581965 ·Status: RECRUITING ·Phase: PHASE4
-
Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
NCT02379663 ·Status: COMPLETED ·Phase: PHASE4
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
NCT00423319 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
NCT00331838 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
NCT00398905 ·Status: COMPLETED ·Phase: PHASE2
-
Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
NCT01354704 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
NCT01203098 ·Status: COMPLETED ·Phase: PHASE2
-
Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty
NCT00657150 ·Status: COMPLETED ·Phase: PHASE3
-
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement
NCT00152971 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Ranging Study in Elective Total Hip Replacement Surgery
NCT00338897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
NCT01431456 ·Status: COMPLETED ·Phase: PHASE3
-
Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events
NCT02987946 ·Status: COMPLETED ·Phase: NA
-
PROphylaxis in NOn Major Orthopaedic Surgery
NCT02401594 ·Status: TERMINATED ·Phase: PHASE3
-
Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery
NCT01344954 ·Status: COMPLETED ·Phase: PHASE2
-
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
NCT00541320 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03891524 ·Status: COMPLETED ·Phase: PHASE2